2021

1. AdrA as a Potential Immunomodulatory Candidate for STING-Mediated Antiviral Therapy That Required Both Type I IFN and TNF-α Production

   Journal of immunology (Baltimore, Md. : 1950), Vol. 206, Núm. 2, pp. 376-385